Johnson & Johnson (JNJ) Stock Price
$162.3 0%
to add to portfolio
AI Score

-
Alternative
5 -
Fundamental
9 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Johnson & Johnson, AI stock picks, stock alerts and much more.
JNJ AI Stock Analysis
Financial Performance
Johnson & Johnson's last reported revenue was $22.5B, a slight increase of 0.1% from the previous quarter and up by 5% year over year. The gross profit was $15.5B, a minor decrease of -0.4% from the previous quarter. However, their operating income showed a significant decline by -64.1% from the previous quarter and down by -47.1% year over year which could be concerning for investors.
The EBITDA ratio in the last quarter was at 0.24 indicating moderate profitability while PE ratio stands at 25.31 suggesting that the stock might be slightly overvalued as per industry standards.
Stock Price
The current stock price is $146.81 with an RSI value of 56.4 indicating it to be neither oversold nor overbought and hence relatively stable in terms of momentum and price movement.
The stock's performance has been somewhat lackluster with a slight month-over-month increase of 0.1%, but it's down by -7.6% on a yearly basis which suggests some volatility in its performance.
Alternative Data Signals
In terms of alternative data signals, there seems to be mixed indicators about Johnson & Johnson's business outlook.
Web traffic shows a declining trend both monthly and yearly which can indicate reduced customer engagement or interest in their products or services online.
A notable surge in job openings suggests potential expansion plans or high employee turnover rate within the company while social media followers show varied trends across different platforms hinting at inconsistent brand popularity among online audiences.
Conclusion
In conclusion, given the mixed signals from financial performance and alternative data indicators, the analysis is neutral on Johnson & Johnson's stock.
Note: This AI Stock Analysis is based on data as of January 23. Our members can refresh and get access to an up-to-date AI stock analysis.
Sign up
Johnson & Johnson (JNJ) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Johnson & Johnson (JNJ), currently trading at $162.3, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About JNJ

-
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide.
-
Symbol
JNJ
-
Market
NYSE
-
Industry
Drug Manufacturers - General
-
Market Cap
390.8B
Similar Stocks
![]() |
Eli Lilly and Company LLY |
$873.7 0.1% |
7 |
![]() |
Pfizer PFE |
$26.3 1.5% |
4 |
![]() |
AbbVie ABBV |
$202.1 0.6% |
6 |
![]() |
Merck & Company MRK |
$89.5 2.1% |
5 |
![]() |
Novartis NVS |
$109.4 1.9% |
6 |
News
JNJ Alternative Data
Web Traffic
Johnson & Johnson receives an estimated 2.4M monthly visitors to jnj.com.
-
Web Traffic
2395386
-
Change from Previous Month
20.3%
-
3 Month Change
5.5%
-
YoY Change
5.5%
News Mentions
Johnson & Johnson was mentioned 190 times in the news yesterday.
-
News Mentions
190
-
Daily Change
37.1%
-
1 Month Change
59.8%
-
3 Month Change
62.9%
Reddit Mentions
Johnson & Johnson has been mentioned an estimated 1 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
1
-
Daily Change
66.7%
Twitter Followers
Johnson & Johnson has 246,455 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.3% over the last month.
-
Twitter Followers
246455
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
0.5%
-
YoY Change
0.5%
Facebook Engagement
Johnson & Johnson has engaged 272 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
272
-
Daily Change
3.4%
-
1 Month Change
23.4%
-
3 Month Change
37.5%
-
YoY Change
37.5%
Instagram Followers
Johnson & Johnson has 99,852 Instagram Followers on its main Instagram account, up by 0.7% over the last month.
-
Instagram Followers
99852
-
Daily Change
0%
-
1 Month Change
0.7%
-
3 Month Change
2.3%
-
YoY Change
2.3%
Youtube Subscribers
Johnson & Johnson has 74,200 subscribers on its main Youtube channel, up by 0.3% over the last month.
-
Youtube Subscribers
74200
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
0.8%
-
YoY Change
0.8%
LinkedIn Followers
9,269,367 are following Johnson & Johnson on LinkedIn, up by 0.5% over the last month.
-
LinkedIn Followers
9269367
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
1.1%
Job Postings
Johnson & Johnson currenly has an estimated 2,000 open job postings.
-
Job Postings
2000
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
-
YoY Change
100%
LinkedIn Employees
According to LinkedIn, Johnson & Johnson has 101,441 employees, down by -0.1% over the last month.
-
LinkedIn Employees
101441
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
0.4%
-
YoY Change
0.4%
Business Outlook
-
Business Outlook
75
-
Change from Previous Month
1.3%
-
3 Month Change
0%
-
YoY Change
0%
JNJ Financials
JNJ Key Metrics
-
Total Revenue
$22.5B
-
Net Income
$2.7B
-
Earnings per Share
$1.11
-
Free cash flow
$5.7B
-
EBITDA
$7.1B
-
EBITDA Ratio
0.315963
-
Total Assets
$178.3B
JNJ 2-year Revenue & Income
JNJ 2-year Free Cash Flow
JNJ Technicals
JNJ SMA
JNJ RSI
FAQ
What's the current price of Johnson & Johnson (JNJ) Stock?
The price of an Johnson & Johnson (JNJ) share is $162.3.
What's the market cap of Johnson & Johnson?
The current market cap of Johnson & Johnson is 390.8B.
Should I buy or sell JNJ?
Johnson & Johnson shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Johnson & Johnson is better viewed as a hold or accumulate position while waiting for further developments.
Is Johnson & Johnson a good investment?
The current analysis of Johnson & Johnson's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Johnson & Johnson's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Johnson & Johnson (JNJ) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Johnson & Johnson stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Johnson & Johnson (JNJ) that investors often compare it to?
Johnson & Johnson (JNJ) is often compared to similar stocks such as Eli Lilly and Company, Pfizer, AbbVie, Merck & Company and Novartis.
What is the forecast for Johnson & Johnson's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Johnson & Johnson's stock price to be around $169.2 in 2026. Starting from the current price of $162.3, this represents a 4.2% change in price, indicating a neutral outlook for the stock.
How to buy Johnson & Johnson (JNJ) Stock?
Johnson & Johnson stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Johnson & Johnson shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.